Home › Funds › APEIRON CAPITAL Ltd › NKTR

APEIRON CAPITAL Ltd position in NKTR

NEKTAR THERAPEUTICS · Health Care

APEIRON CAPITAL Ltd reported holding 51,400 shares of NKTR (NEKTAR THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 4.87% of its reported portfolio and ranking #6 among its reported holdings. APEIRON CAPITAL Ltd has disclosed NKTR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)51.40K sh
Reported value held$3.59M
Portfolio Weight4.87%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How APEIRON CAPITAL Ltd's NKTR position evolved

APEIRON CAPITAL Ltd first disclosed a stake in NKTR in Q2 2026 at 106,431 shares (US$7.4M). Across 2 filings, APEIRON CAPITAL Ltd increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 51,400 shares valued at US$3.6M — a reduction of -55,031 shares quarter over quarter.. Notable position changes include a 52% trim in Q3 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 106.43K $7.43M New
Q3 2026 51.40K $3.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS) is a Health Care company. 58 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has APEIRON CAPITAL Ltd held NKTR?

APEIRON CAPITAL Ltd has disclosed NKTR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is APEIRON CAPITAL Ltd's current position in NKTR?

As of Q3 2026, APEIRON CAPITAL Ltd holds 51.40K shares of NKTR (NEKTAR THERAPEUTICS), valued at $3.59M, representing 4.87% of its reported portfolio and ranking #6.

Has APEIRON CAPITAL Ltd been buying or selling NKTR?

In the latest 13F filing (Q3 2026), APEIRON CAPITAL Ltd reduced its position in NKTR.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.